4Blum JE, Handmaker H. Role of small - peptide radiopharmaceuticals in the evaluation of deep venous thrombosis [ J ]. Radiographics, 2002, 20(4) :1187
3Girard P,Musset D,Parent F,et al.High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism[].Chest.1999
4Kahn SR.The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs[].Archives of Internal Medicine.1998
5Wells PS,Anderson DR,Bormanis J,et al.Value of assessment of pretest probability of deep-vein thrombosis in clinical management[].The Lancet.1997
6Tapson VF,Carroll BA,Davidson BL,et al.The diagnostic approach to acute venous thromboembolism.Clinical practice guideline. American Thoracic Society[].American Journal of Respiratory and Critical Care Medicine.1999
7Ferrari E,Baudouy M,Cerboni P,et al.Clinical epidemiology of venous thromboembolic disease.Results of a French Multicentre Registry[].European Heart Journal.1997
8Hyers TM.Venous Thromboembolism[].American Journal of Respiratory and Critical Care Medicine.1999
9Mewissen MW,Seabrook GR,Meissner MH,et al.Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry[].Radiology.1999
10Ouriel K,Gray B,Clair DG,et al.Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis[].Journal of Vascular and Interventional Radiology.2000
